Express Scripts Raises Its Outlook for Selling Season
We are reiterating our $89 fair value estimate and wide moat rating for the healthcare services player.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.